8-KOther EventsExhibits & Filings

AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Oct 12, 2007)

Filed October 12, 2007For Securities:A

Summary

Agilent Technologies, Inc. filed this Form 8-K on October 12, 2007, to provide updated financial and business segment information. The primary purpose is to incorporate these changes into a prospectus for employee stock plans and future registration statements. This filing does not introduce new financial results but rather recasts prior disclosures to reflect significant organizational and reporting methodology adjustments. The key adjustments include the transfer of the nanotechnology measurement business from the electronic measurement segment to the bio-analytical measurement segment, effective in the third quarter of 2007. Additionally, Agilent has revised its methodology for defining and reporting market and sub-market data for its products, affecting categories like "communications test," "general purpose test," "life sciences," and "chemical analysis." These changes have been retroactively applied to previously filed financial reports, including the Annual Report on Form 10-K for the year ended October 31, 2006, and the Quarterly Reports for the periods ending January 31, 2007, and April 30, 2007.

Key Highlights

  • 1Agilent Technologies is filing an 8-K to incorporate updated segment and market data into employee stock plan prospectuses and future SEC filings.
  • 2The nanotechnology measurement business has been moved from the 'electronic measurement' segment to the 'bio-analytical measurement' segment.
  • 3A new methodology for defining market and sub-market data (e.g., 'communications test,' 'life sciences') has been implemented.
  • 4Prior period financial information in the Form 10-K (FY2006) and Form 10-Q (Q1 & Q2 2007) has been recast to reflect these changes.
  • 5This filing serves primarily as a disclosure update and does not present new financial results or operational performance changes beyond the structural and reporting methodology adjustments.
  • 6The Report of Independent Registered Public Accounting Firm and Management's Report on Internal Control over Financial Reporting from the Annual Report on Form 10-K are included without change.

Frequently Asked Questions

The primary reason for this Form 8-K filing is to incorporate updated business segment information and changes in market/sub-market data reporting methodology into Agilent's prospectus for employee stock plans and any future registration statements. It's an administrative filing to ensure consistency in disclosures.

No, this filing does not present new financial results. It recasts historical financial information and business segment data to reflect the organizational change and revised reporting methodology. The actual financial performance of the company remains as previously reported, but it is now presented under a new structure and definitions.

Agilent has moved its nanotechnology measurement business from the electronic measurement segment to the bio-analytical measurement segment. This change was effective at the beginning of the third quarter of 2007.

The new methodology affects how Agilent categorizes and reports revenue and order information based on the markets its products are sold into. Key categories like 'communications test,' 'general purpose test,' 'life sciences,' and 'chemical analysis' have been redefined, requiring a restatement of historical data for better alignment with the company's current business focus.